SERPLULIMAB vs SIMVASTATIN: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
SERPLULIMAB vs SIMVASTATIN: Safety Overview
| Metric | SERPLULIMAB | SIMVASTATIN |
|---|---|---|
| Total FAERS Reports | 137 | 27,079 |
| Deaths Reported | 36 | 2,792 |
| Death Rate | 26.3% | 10.3% |
| Hospitalizations | 81 | 8,824 |
| Average Patient Age | 63.0 yrs | 66.6 yrs |
| % Female Patients | 11.1% | 47.5% |
| FDA Approval Date | N/A | Apr 14, 2009 |
| Manufacturer | N/A | Aphena Pharma Solutions - Tennessee, LLC |
| Route | N/A | ORAL |
| Marketing Status | N/A | Prescription |